HK1028241A1 - Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic - Google Patents

Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic

Info

Publication number
HK1028241A1
HK1028241A1 HK00106804A HK00106804A HK1028241A1 HK 1028241 A1 HK1028241 A1 HK 1028241A1 HK 00106804 A HK00106804 A HK 00106804A HK 00106804 A HK00106804 A HK 00106804A HK 1028241 A1 HK1028241 A1 HK 1028241A1
Authority
HK
Hong Kong
Prior art keywords
antiepileptic
difluorobenzyl
carboxamide
triazole
crystal modification
Prior art date
Application number
HK00106804A
Other languages
English (en)
Inventor
Robert Portmann
Urs Christoph Hofmeier
Andreas Burkhard
Walter Scherrer
Martin Szelagiewicz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4209650&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1028241(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1028241A1 publication Critical patent/HK1028241A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK00106804A 1997-06-10 2000-10-25 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic HK1028241A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH140497 1997-06-10
PCT/EP1998/003427 WO1998056772A1 (en) 1997-06-10 1998-06-08 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3--triazole-4-carboxamide and its use as antiepileptic

Publications (1)

Publication Number Publication Date
HK1028241A1 true HK1028241A1 (en) 2001-02-09

Family

ID=4209650

Family Applications (3)

Application Number Title Priority Date Filing Date
HK00106807A HK1028242A1 (en) 1997-06-10 2000-10-25 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3,-triazole-4-carboxamide and its use as antiepileptic
HK00106804A HK1028241A1 (en) 1997-06-10 2000-10-25 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic
HK00107340A HK1028031A1 (en) 1997-06-10 2000-11-17 Crystal modification of 1-(2,6-difluorobenzyl)-IH-1,2,3-triazole-4-carboxamide and its use as antiepileptic.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK00106807A HK1028242A1 (en) 1997-06-10 2000-10-25 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3,-triazole-4-carboxamide and its use as antiepileptic

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK00107340A HK1028031A1 (en) 1997-06-10 2000-11-17 Crystal modification of 1-(2,6-difluorobenzyl)-IH-1,2,3-triazole-4-carboxamide and its use as antiepileptic.

Country Status (37)

Country Link
US (6) US6740669B1 (es)
EP (2) EP0994863B1 (es)
JP (2) JP3672574B2 (es)
KR (2) KR100409168B1 (es)
CN (3) CN1132820C (es)
AR (4) AR012945A1 (es)
AT (2) ATE237599T1 (es)
AU (2) AU725528B2 (es)
BR (2) BR9804947A (es)
CA (3) CA2256015C (es)
CO (2) CO4940448A1 (es)
CY (1) CY2007014I1 (es)
CZ (2) CZ292481B6 (es)
DE (3) DE69813560T2 (es)
DK (2) DK0994864T3 (es)
ES (2) ES2197485T3 (es)
FR (1) FR07C0037I2 (es)
HK (3) HK1028242A1 (es)
HU (2) HU226107B1 (es)
ID (2) ID27660A (es)
IL (2) IL125733A (es)
LU (1) LU91345I2 (es)
MY (2) MY120156A (es)
NL (1) NL300284I2 (es)
NO (2) NO329315B1 (es)
NZ (2) NZ331371A (es)
PE (2) PE79799A1 (es)
PL (2) PL191943B1 (es)
PT (1) PT994864E (es)
RU (2) RU2194041C2 (es)
SI (2) SI0994864T1 (es)
SK (2) SK283734B6 (es)
TR (2) TR199801631T1 (es)
TW (2) TW526195B (es)
UY (1) UY25844A1 (es)
WO (2) WO1998056773A1 (es)
ZA (2) ZA984966B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526195B (en) 1997-06-10 2003-04-01 Novartis Ag Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use
WO2003101991A1 (en) * 2002-05-31 2003-12-11 Schering Corporation Xanthine phosphodiesterase v inhibitor polymorphs
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US20090069390A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched rufinamide
CA2736703A1 (en) * 2008-10-13 2010-04-22 Cipla Limited Process for the preparation of rufinamide
CN101768124B (zh) * 2008-12-30 2012-01-04 北京本草天源药物研究院 一种药物晶体及其制备方法和用途
IT1395736B1 (it) * 2009-08-04 2012-10-19 Dipharma Francis Srl Forme cristalline di rufinamide
JP2013503861A (ja) * 2009-09-04 2013-02-04 タクティカル セラピューティクス インコーポレイテッド 新規の組成物、ならびに５−アミノまたは置換アミノ１，２，３−トリアゾールおよびトリアゾールオロチン酸塩製剤を調製する方法
EP2465853A1 (en) 2010-12-14 2012-06-20 Laboratorios Lesvi, S.L. Polymorph of rufinamide and process for obtaining it
WO2011135105A1 (en) 2010-04-30 2011-11-03 Laboratorios Lesvi, S.L. Improved process for preparing rufinamide intermediate
ITMI20110718A1 (it) 2011-04-29 2012-10-30 Dipharma Francis Srl Procedimento per la purificazione di rufinamide
US10206874B2 (en) 2012-07-20 2019-02-19 Hetero Research Foundation Rufinamide solid dispersion
WO2021099481A1 (en) 2019-11-20 2021-05-27 Medichem, S.A. Solid composition containing rufinamide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
US4156734A (en) * 1976-02-13 1979-05-29 Merck & Co., Inc. Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid
GB1511195A (en) 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4346097A (en) * 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives
US4789680A (en) * 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
FI834666A (fi) 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4511572A (en) * 1983-03-18 1985-04-16 The University Of Kentucky Research Foundation Triazoline anticonvulsant drugs
PH22568A (en) * 1985-04-18 1988-10-17 Ciba Geigy Ag Fluorinated benzyl triazoles and pharmaceutical compositions containing the same
CA2002864C (en) 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
JPH02214504A (ja) 1989-02-15 1990-08-27 Nissan Chem Ind Ltd 光学活性キノキサリン化合物の晶析法
JPH04506967A (ja) 1989-07-27 1992-12-03 ジー．ディー．サール　アンド　カンパニー 高血圧症治療用腎選択性生成物
IL96507A0 (en) 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
EP0556393B1 (en) 1990-11-06 2000-07-26 Yamanouchi Pharmaceutical Co. Ltd. Fused pyrazine derivative
JP2753911B2 (ja) 1991-12-06 1998-05-20 キッセイ薬品工業株式会社 Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
DE4217952A1 (de) 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
GB9418443D0 (en) 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
GB9419318D0 (en) 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
KR100419355B1 (ko) 1995-02-22 2004-06-04 훽스트파마슈티칼스앤드케미칼스가부시키가이샤 무정형피레타나이드,피레타나이드다형체,이들의제조방법및이를포함하는약제학적조성물
AU719148B2 (en) * 1996-07-11 2000-05-04 Novartis Ag Process for preparing 1-substituted 4-cyano-1,2,3-triazoles
TW526195B (en) * 1997-06-10 2003-04-01 Novartis Ag Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use

Also Published As

Publication number Publication date
ES2197485T3 (es) 2004-01-01
CN1159300C (zh) 2004-07-28
CZ253498A3 (cs) 1999-04-14
AR012946A1 (es) 2000-11-22
TR199801630T1 (xx) 1999-06-21
DK0994864T3 (da) 2003-07-21
US6740669B1 (en) 2004-05-25
CA2256015A1 (en) 1998-12-17
CZ292481B6 (cs) 2003-09-17
CA2614926A1 (en) 1998-12-17
DE69813560D1 (de) 2003-05-22
WO1998056772A1 (en) 1998-12-17
LU91345I9 (es) 2018-12-31
US20040167186A1 (en) 2004-08-26
CO4940448A1 (es) 2000-07-24
SK283685B6 (sk) 2003-12-02
TW526195B (en) 2003-04-01
KR100409168B1 (ko) 2004-01-31
CN1572789A (zh) 2005-02-02
IL125732A0 (en) 1999-04-11
NO983666D0 (no) 1998-08-11
SK109398A3 (en) 1998-12-02
FR07C0037I1 (es) 2007-08-17
PL330764A1 (en) 1999-05-24
PT994864E (pt) 2003-07-31
TR199801631T1 (xx) 1999-06-21
SK283734B6 (sk) 2003-12-02
PL191943B1 (pl) 2006-07-31
EP0994863A1 (en) 2000-04-26
SI0994864T1 (en) 2003-10-31
AU725517B2 (en) 2000-10-12
NO329315B1 (no) 2010-09-27
US20010037029A1 (en) 2001-11-01
NZ331371A (en) 2000-08-25
US20030125568A1 (en) 2003-07-03
FR07C0037I2 (es) 2008-05-16
KR100425656B1 (ko) 2004-05-17
PL192114B1 (pl) 2006-08-31
ZA984967B (en) 1999-01-11
PL330798A1 (en) 1999-06-07
MY120156A (en) 2005-09-30
DE69811500T2 (de) 2004-04-01
NO329314B1 (no) 2010-09-27
NL300284I2 (nl) 2007-11-01
CZ292260B6 (cs) 2003-08-13
EP0994864B1 (en) 2003-04-16
NL300284I1 (nl) 2007-10-01
NO983667D0 (no) 1998-08-11
IL125733A0 (en) 1999-04-11
HUP0002113A2 (hu) 2001-02-28
CA2256013A1 (en) 1998-12-17
CA2614926C (en) 2010-02-09
CY2007014I2 (el) 2009-11-04
NZ331370A (en) 2000-08-25
AU725528B2 (en) 2000-10-12
CO4940452A1 (es) 2000-07-24
ID27660A (id) 2001-04-19
CN1259127A (zh) 2000-07-05
NO983667L (no) 1998-12-17
PE80999A1 (es) 1999-09-06
KR19990087836A (ko) 1999-12-27
CN1298708C (zh) 2007-02-07
DK0994863T3 (da) 2003-05-26
JP3672575B2 (ja) 2005-07-20
ATE232852T1 (de) 2003-03-15
IL125732A (en) 2002-12-01
CZ253398A3 (cs) 1999-04-14
CY2007014I1 (el) 2009-11-04
DE122007000051I1 (de) 2007-11-08
SI0994863T1 (en) 2003-08-31
RU2198167C2 (ru) 2003-02-10
JP2000516258A (ja) 2000-12-05
HUP0000798A2 (hu) 2000-10-30
ID21014A (id) 1999-04-08
AR061005A2 (es) 2008-07-30
BR9804947A (pt) 1999-08-24
PE79799A1 (es) 1999-09-03
US6455556B2 (en) 2002-09-24
HK1028031A1 (en) 2001-02-02
BR9804946A (pt) 1999-08-24
UY25844A1 (es) 2001-08-27
WO1998056773A1 (en) 1998-12-17
LU91345I2 (fr) 2007-09-04
DE122007000051I2 (de) 2009-02-19
CA2256015C (en) 2008-06-03
NO983666L (no) 1998-12-17
HU225153B1 (en) 2006-07-28
HK1028242A1 (en) 2001-02-09
ES2192779T3 (es) 2003-10-16
ZA984966B (en) 1999-01-11
CN1217716A (zh) 1999-05-26
HUP0000798A3 (en) 2000-10-30
AU8437298A (en) 1998-12-30
JP3672574B2 (ja) 2005-07-20
AR012945A1 (es) 2000-11-22
DE69813560T2 (de) 2004-02-05
HUP0002113A3 (en) 2002-09-30
CA2256013C (en) 2007-10-16
HU226107B1 (en) 2008-04-28
EP0994863B1 (en) 2003-02-19
DE69811500D1 (de) 2003-03-27
AU8437198A (en) 1998-12-30
AR061004A2 (es) 2008-07-30
US20060116520A1 (en) 2006-06-01
KR19990087835A (ko) 1999-12-27
RU2194041C2 (ru) 2002-12-10
TW403740B (en) 2000-09-01
SK109498A3 (en) 1998-12-02
IL125733A (en) 2002-12-01
JP2000516259A (ja) 2000-12-05
US20100310655A1 (en) 2010-12-09
ATE237599T1 (de) 2003-05-15
EP0994864A1 (en) 2000-04-26
CN1132820C (zh) 2003-12-31
MY125854A (en) 2006-08-30
US8076362B2 (en) 2011-12-13
US7750028B2 (en) 2010-07-06

Similar Documents

Publication Publication Date Title
NL300284I1 (nl) Kristalmodificatie van 1-(2,6-difluorbenzyl)1H-1,2,3-triazool-4-carboxamide en de toepassing daarvanals anti-epilepticum.
ZA985867B (en) Triazole compounds and their use.
EP0871444A4 (en) 2.5 SUBSTITUTED ARYL PYRROL, THE COMPOSITIONS THAT CONTAIN AND THE USE THEREOF
GB2342741B (en) Transmission unit recieving and storing means
IL130778A0 (en) 4-(3-Heterocyclyl -1-benzoyl) pyrazoles and their use as herbicides
IL127212A0 (en) Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
AU4009795A (en) Heterocyclic compounds and their use
GB9827295D0 (en) Ferroelectric imaging member and metyhods of use
AU5399096A (en) Combination compositions containing benazepril or benazeprilat and valsartan
AU1808495A (en) Substituted triazolinones and their use as herbicides
AU7569496A (en) Water-based solvant-free and emulsifier-free microbicidal combination of active substances
AU1081897A (en) Heterocyclic compounds and their use
HK1011020A1 (en) Triazole derivatives with antimycotic action and intermediates
TH9801002100B (th) รูปแบบโครงสร้างผลึกดัดแปลงของ 1-(2,6-ไดฟลูออโรเบนซิล)-1h-1,2,3-ไตรอาโซล-4-คาร์บอกซาไมด์
HK1015687A1 (en) Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents.
AU1141497A (en) Heterocyclic compounds and their use
ZA981321B (en) Novel use of azoles
HUP9904285A3 (en) Bleaching composition and its use
TW381444U (en) Structure of grain storing and selling barrels
AU4621997A (en) Substituted carbamoyl triazoles and their use as herbicides
SE9500568D0 (sv) Lastnings- och lossningshjälpmedel

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20180607